Cardiorenal Outcomes Among Patients With Atrial Fibrillation Treated With Oral Anticoagulants (IMAGE)

National Kidney Foundation

Cardiorenal Outcomes Among Patients With Atrial Fibrillation Treated With Oral Anticoagulants

Caption

Among patients with non-valvular AF treated in routine clinical practice, compared with VKA, DOAC use was associated with a lower risk of CKD progression, AKI, and major bleeding, but a similar risk of the composite of stroke/systemic embolism and death. (Trevisan et al, AJKD 2022)

Credit

Visual Abstract for "Cardiorenal Outcomes Among Patients With Atrial Fibrillation Treated With Oral Anticoagulants" by Trevisan et al (AJKD 2022)

Usage Restrictions

Credit must be given to the creator. Only noncommercial uses of the work are permitted. Adaptations must be shared under the same terms.

License

CC BY-NC-SA

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.